A股異動 | 元祖股份(603886.SH)漲超6% 績後獲券商看好
格隆匯4月22日丨元祖股份(603886.SH)股價繼續走強,盤中最大漲幅約7.6%,現報19.97元,最新總市值47.93億,月內累計漲逾13%。公司19日公吿稱,2020年實現營業收入23.03億元,同比增長3.63%;歸屬於上市公司股東的淨利潤3.00億元,同比增長21.09%;擬10派10元。華泰證券指,20年公司業績穩健增長,主要受益於19年提價放量效果逐步兑現和20年下半年需求恢復較好。20年銷售商品、提供勞務收到的現金同比+7.9%,經營現金流淨額為4.8億,同比+41.5%。看好公司穩健增長的持續性,預計21-23年EPS為1.43/1.67/1.90元,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.